Find and Pitch Jounalists, Get Your Story Covered

Tags: MDMA ecstasy PTSD therapy care continuum communication

	Profile	Recent Articles on Subject
1	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about lower Wegovy prices, a dispute over Merck’s Keytruda, and more - about 2 months ago STAT+: Pharmalittle: We’re reading about Medicare plans to negotiate obesity-drug prices, a Novartis 340B lawsuit, and more - 3 months ago STAT+: Feds threaten Sanofi with sanctions over plan to change payment terms for a federal drug discount program - 4 months ago STAT+: Pharmacies sue GoodRx and PBMs over ‘illegal’ reimbursement fees - 6 months ago STAT+: Two generic drugmakers to pay $49 million to settle price-fixing charges - 6 months ago STAT+: Sales from controversial drug discount program rose to $63 billion last year - 6 months ago STAT+: Pharmalittle: We’re reading about FTC scrutiny of a Novo deal, a Genentech reorganization, and more - 8 months ago STAT+: Pharmalittle: We’re reading about AbbVie spending on doctors, a new Lilly deal, and more - 10 months ago STAT+: Pharmalittle: We’re reading about drug shortages, Medicare spending on an Alzheimer’s drug, and more - about 1 year ago STAT+: Pharmalittle: We’re reading about a European probe into vaccine talks; net drug prices falling, and more - about 1 year ago STAT+: Many costly generic drugs are unavailable at Amazon, Cuban, and other alternative pharmacies - about 1 year ago STAT+: Pharmalittle: We’re reading about state moves on drug pricing, an asthma med for kids and more - about 1 year ago STAT+: Pharmalittle: We’re reading about drug price hikes, Bayer strategic moves, and more - over 1 year ago STAT+: Pharmalittle: Drugmakers raise prices, pharmacies fear fees, McKinsey settles - over 1 year ago STAT+: Pharmalittle: U.S. to impose inflation penalties on dozens of drugmakers; Supreme Court will decide abortion pill access - over 1 year ago STAT+: The prices of 8 drugs were hiked without proof of new benefits, costing the U.S. $1.2 billion in 2022, report finds - over 1 year ago STAT+: Pharmalittle: White House takes aim at pharma patents to lower drug prices; Sanofi CEO defends reducing earnings forecast - over 1 year ago STAT+: Pharmalittle: U.S. Senate eyes more policies for regulating PBMs; Novo claims most U.S. Wegovy patients pay less than $25 a month - over 1 year ago STAT+: Medicare is urged to consider Amgen patent maneuvers when negotiating the price for a drug - over 1 year ago STAT+: Pharmalittle: Pharma moves closer to a pricing deal with U.K.; FDA to review AstraZeneca request for self-administered flu vax - over 1 year ago STAT+: Medicare may plan to negotiate drug prices, but some states are taking their own steps to lower costs - over 1 year ago STAT+: Pharmalittle: U.S. Chamber and feds clash on Medicare price negotiation; South Africa probes J&J over TB-drug pricing - over 1 year ago
2	Michael Gibney Pharma Voice Teacher of English. Teacher of politics. Santiago, Chile educationpolitics	Medicare’s next list of drugs for price negotiation could get ‘very interesting’ — and have a bigger impact on pharma - 2 months ago Tariffs raise concern among generic drugmakers, and advocacy groups are seeking exemptions - 3 months ago $4M+ gene therapies? How payers can adapt to a new reality of pricey ‘cures’ - 12 months ago
3	Beth Mole Ars Technica Senior Health Reporter @ArsTechnica. microbiologyinfectious diseasespublic health	Wegovy and Ozempic top list of 15 drugs up for next price negotiations - 3 months ago Novo Nordisk sells hit weight-loss drug in China—at fraction of US price - 5 months ago Medicare drug price negotiations: 10 list prices drop between 38% to 79% - 8 months ago Big Pharma’s fight against drug price reforms takes weird, desperate turn - 10 months ago Big Pharma fought drug pricing reform with record $7.5M dark money donation - over 1 year ago
4	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	What to expect in the sequel to Medicare’s drug price negotiation program - 3 months ago The drugs hit hardest by Medicare price negotiations - 8 months ago Pharma execs react to final drug price negotiations with Medicare - 9 months ago 3 Big Pharma cancer drugs facing inflation penalties - 9 months ago The IRA will lower U.S. drug spending, CMS finds — but not for awhile - 10 months ago Cutting pills. Rationing insulin. How Americans struggle to pay for drugs. - about 1 year ago Could pharma’s legal attack on the IRA succeed in killing price negotiations? - about 1 year ago
5	Emily Olsen Healthcare Dive Reporter at Healthcare Dive. Loyola, Medill alum. Chicago, Illinois HealthcareNews	Aetna sues drugmakers over alleged price-fixing scheme - 4 months ago
6	Shannon Firth MedPage Today Washington correspondent for MedPageToday. CUNYJschool pride. Healthcarejournalism	Experts Weigh Benefits of Drug Price Negotiation and Other Price-Curbing Strategies - 4 months ago Drug Prices Negotiated by Medicare Still Higher Than Other Countries' - 5 months ago What's Happening With the Medicare Drug-Price Negotiation Lawsuits? - about 1 year ago Medical Schools Push Back on 'March-In' Rights Plan to Lower Drug Prices - about 1 year ago Experts, Lawmakers Explore Downside of Drug-Price Negotiation - over 1 year ago White House Says It Can Seize Certain Drug Patents to Lower Prices - over 1 year ago
7	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	Is anyone taking the world’s priciest drugs? - 8 months ago
8	Joyce Frieden MedPage Today Washington editor at MedPage Today. Board member at AHCJ. Greater Washington, DC area Healthcare journalism	Is Medicare's Negotiated Drug Price List Worth Celebrating? Depends on Whom You Ask. - 8 months ago Biden Administration Announces Moves to Cut Drug Prices - over 1 year ago States Making Progress Toward Setting Payment Limits for Some Drugs - over 1 year ago
9	Jonathan Gardner Healthcare Dive Senior reporter. BioPharma Dive. Charlottesville, Virginia BiopharmaceuticalsJournalism	Medicare drug price cuts could have limited early impact, but grow with time - 8 months ago
10	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	CMS Touts First Negotiated Drug Prices, But Greater Impact Expected in Future Rounds - 8 months ago

Journalists covering drug pricing